Pronounced mononuclear leukocyte (MNL) inflitration occurs in multiple organs of mice homozygous for a transforming growth factor 131 (TGF-fl) loss-of-ftunction gene mutation [TGF-1l1 (-/-)J, followed by cachexia and eventually death. Consistent with the Increased leukocyte adhesion and tissue infiltration, MNUs isolated from spleen, thymus, and peripheral blood of symptomatic TGF-I81 (-/-) 
mice, as compared to littermate controls, exhibited increased adhesion to extracellular matrix proteins and to endothelial cells in vitro. Incubation of TGF-.31 (-/-) MNLs with selected synthetic peptides corresponding to cell-and heparin-binding sequences of fibronectin (FN) ficantly attenuated adhesion of these cells not only to FN but also to endothellal cells in vitro. Based on these observations, mice were treated with the FN peptides in an attempt to rescue them from tissue inflammation and cardiopulmonary failure. Daily injections ofa combination of four synthetic FN peptides that interact with fil-integrins and/or cell surface proteoglycans blocked the massive infiltration of MNLs into the heart and lungs of TGF-131 (-/-) mice. Peptide treatment initiated on day 8, coincident with the first evidence of increased leukocyte-endothellal cell interactions, not only blocked tissue infiltration but also moderated the lethal wasting syndrome.
Transforming growth factor (3 (TGF-j3) is a 25-kDa peptide that is produced by virtually all cells of the body (1) . In mammalian species, TGF-(3 exists as three isoforms, TGF- ,31, -(32, and -(33, but TGF-P1 has the widest tissue distribution (1, 2) . To explore its role in development, growth, and other fundamental biological processes, mice deficient in a functional TGF-(31 gene [TGF-(31 (-/-)] were generated (3, 4) . Although circumstantial evidence had suggested that TGF-(31 might be essential for embryogenesis (5, 6) , nearly 40%o of the homozygous TGF-(31 (-/-) mice were born healthy and without obvious disfigurement. However, within [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] days, the TGF-f31 (-/-) mice began to experience a wasting syndrome, and shortly after becoming symptomatic, the mice succumbed. Histopathological analysis of the tissues from symptomatic TGF-P1 (-/-) mice revealed dramatic numbers of mononuclear leukocytes (MNLs) in vital organs, such as heart and lung, which virtually obliterated the parenchyma, leading to organ failure and death (3, 4, 7) .
Based on the potent immunosuppressive and anti-inflammatory properties of TGF-/31 (8, 9) , it was suspected that the absence of TGF-f31 was responsible for uncontrolled leukocyte recruitment and activation resembling chronic inflammatory disease-associated pathology (8) (9) (10) . However, the etiologic basis for the onset of this rampant "inflammation" remains unclear, although recent evidence of elevated major histocompatibility complex (MHC) expression suggests autoimmune-like mechanisms (11) . The earliest detectable alteration in MHC class I and II antigens occurs in some tissues on day 6 postpartum (11), around the time that leukocyte adherence in otherwise normal-appearing tissue occurs. Leukocyte adhesion to endothelium and to extracellular matrix (ECM) components has a complex molecular basis. The initial trafficking of circulating leukocytes to sites of inflammation is mediated by the selectin family of adhesion receptors (12) (13) (14) (15) (16) , followed by engagement of additional cellular recognition receptors, including members of the immunoglobulin superfamily and integrins (13) (14) (15) . Although less understood, there is also increasing evidence for a role of cell surface proteoglycans in mediating early steps in the inflammatory response (16) (17) (18) (19) (20) (21) .
Since modulation of leukocyte adhesion represents a key step in the development of inflammation, we evaluated the role of adhesion molecules in the massive tissue infiltration in TGF-l31-deficient mice. MNLs MATERIALS AND METHODS Animals. TGF-(31 (-/-) mice were generated following targeted disruption of the TGF-j31 gene in mouse embryonic stem cells as described (4) . Mouse genotype was verified by PCR analysis of tail DNA (11) .
Spleen, Thymus, and Blood MNLs. Thymus and spleen were removed from littermates with a wild-type (+/+), heterozygous (+/-), or null (-/-) TGF-(31 genotype, and single-cell suspensions were prepared as described (22 (26) (27) (28) . FN polypeptides containing the arginylglycylaspartic acid (RGD) domain, the alternatively spliced connecting segment (CS-1), and two nonoverlapping sequences corresponding to the FN-C/H region (FN-C/H-I, Tyr-Glu-Lys-Pro-Gly-Ser-ProPro-Arg-Glu-Val-Val-Pro-Arg-Pro-Arg-Gly-Val; FN-C/ H-V, Trp-Gln-Pro-Pro-Arg-Ala-Arg-Ile) were synthesized and purified as described (26, 27) . Because of the limited availability of TGF-,B1 (-/-) mice, the animals received daily i.p. injections (0.4 mg/100 td) of a pool of the four peptides for 14-19 days. To evaluate the effect ofthe peptides on tissue pathology, excised tissues were fixed in 10% formalin, embedded in paraffin, sectioned (5 ,Lm), and stained with hematoxylin/eosin for histological analysis.
RESULTS
Leukocyte Inftration in Tissues of TGF-P1 (-/-) Mice. Although initially appearing normal, --1 week postpartum, mice homozygous for the TGF-31 null mutation (-/-) began to exhibit leukocyte adherence to endothelium, followed by tissue infiltration (Fig. 1) . No leukocyte adhesion was evident in tissues from 3-day-old mice ( Fig. 1A) , but significant numbers of leukocytes adhered to the vessel walls by [7] [8] days ( Fig. 1 B and C) . By 3 weeks, the heart and lungs were typically infiltrated with massive numbers of leukocytes, with fewer cells remaining adherent on the lumenal side ofthe vessel (Fig. 1D) . Not all tissues were uniformly affected, but within 2-3 weeks, nearly 100% of the null homozygotes exhibited both lung and cardiac lesions (4, 7) . Whereas the lungs exhibited a multifocal mixed leukocyte infiltrate, predominantly mononuclear phagocyte attachment and infiltration were associated with lesions in myocardium (Fig. 2) . The continued accumulation of macrophages in these sites nearly obliterated the parenchyma (Fig. 2 littermates (47 ± 12 and 45 ± 5, respectively; P < 0.05).
Similarly, TGF-O31 (-/-) MNLs adhered more readily to (Fig. 5 ), experiments were initiated to administer these peptides therapeutically to the mice. Daily systemic injections of pooled CS-1, RGD, FN-C/H-I, and FN-C/H-V were initiated on day 7 or 8 postpartum, since leukocyte adhesion to the vessel wall first becomes apparent at this time, and were continued for 12-19 days. As represented by the heart and lungs, FN peptide administration resulted in a virtual block of leukocyte infiltration into the tissues of two treated animals ( Fig. 2 C and F) . Whereas the TGF-,Bi (-/-) littermate that did not receive FN peptides exhibited characteristic inflammatory cells in the myocardium (Fig. 2E) , the hearts from the TGF-,Bi (-/-) littermates that were the recipients of daily peptide therapy contained few, if any, inflammatory cells (Fig. 2F) and appeared more like the wild-type TGF-P31 (+/+) tissues (Fig. 2D) . A similar pattern of interruption of leukocyte infiltration by the peptides was evident in the lungs (Fig. 2 A-C As a marker of symptomatology, animal weight was monitored, and as shown in Fig. 6 , peptide treatment appeared to moderate the typical plateau and loss of weight evident in the untreated TGF-,13 (-/-) mouse. Although considerable variability in weight loss and other symptoms occurred, there was a correlation between peptide inhibition of tissue pathology (Fig. 2) and inhibition of weight loss (Fig. 6 ). In the littermates represented in Fig. 6 , the TGF-,B1 (-/-) mouse with the lowest weight, and perhaps most difficult to rescue, was selected for treatment, and even in this animal, the peptides not only blocked tissue infiltration but also inhibited weight loss.
DISCUSSION
In the present study, we demonstrate that adhesion of leukocytes to vascular endothelium is the earliest morphologically detectable event associated with inflammatory lesions and cachexia in TGF-,81 (-/-) mice. Although no adherence is detected in 3-day-old animals, around 1 week after birth, adhesion and infiltration began and continued until certain target tissues became obstructed with accumulating leukocyte infiltrates. Furthermore, blood, thymus, and TGF-pl (v-) therapy in the current studies, have been shown to individually inhibit adhesion of both normal and transformed cells (19, 29) and to suppress arthritis in an experimental animal model, whereas control peptides including arginylglycylglutamic acid were inactive (27, 28) . The effectiveness of these selected peptides implicates, at the minimum, 81 integrins and likely cell surface proteoglycans, as critical mediators of the increased MNL adhesion and recruitment in these mice. Integrin-mediated adhesion events are complex and susceptible to numerous regulatory mechanisms (13) (14) (15) . In the TGF-,B1 null mice, phenotypic analysis revealed a modest increase in VLA-4, the receptor for both endothelial VCAM-1 and the CS-1 domain of FN, although enhanced cell-cell and cell-matrix interactions are not dependent upon increased expression but may reflect activation of these molecules (13) (14) (15) (27, 30) would also counteract leukocyte-binding patterns in the TGF-131 null animals.
As cationic, hydrophilic peptides, FN-C/H-I and FN-C/ H-V adhere to cell surface proteoglycans and also interact with a4 subunits (18) , presumably blocking proteoglycan and a4-dependent adhesion. Cell surface proteoglycans, which mediate a spectrum of cell-binding activities (17) (18) (19) (20) (21) 
